1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, May 2016 (p6)

Biological Therapy Analysis & Statistics, May 2016 (p6)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

151-180 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile

Interleukin Genetics, Inc. (ILIU) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2016
  • by Global Data

Summary Interleukin Genetics, Inc. (Interleukin) is a molecular diagnostics company. It develops and distributes genetic tests for the personalized health market. Its major genetic tests include PerioPredict ...

  • Industries : General Medicine and Specialty Medicine
Juvaris BioTherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Juvaris BioTherapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2016
  • by Global Data

Summary Juvaris BioTherapeutics, Inc. (Juvaris) is a pharmaceutical company that develops adjuvanted vaccines and immunotherapeutics to treat cancer and infectious disease in the fields of human and animal ...

  • Industries : Biological Therapy, Pharmaceutical
Atara Biotherapeutics, Inc. (ATRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Atara Biotherapeutics, Inc. (ATRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2016
  • by Global Data

Summary Atara Biotherapeutics, Inc. (Atara) is a clinical-stage biopharmaceutical company that develops therapies for medical needs. The company develops drugs for muscle wasting conditions and cancer. ...

  • Industries : Biological Therapy
  • Countries : United States
Cell Therapy Catapult Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Cell Therapy Catapult Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2016
  • by Global Data

Summary Cell Therapy Catapult Limited (Catapult), d/b/a Cell and Gene Therapy Catapult, is a biotechnology company that develops, delivers and commercializes cell and gene therapies. The company helps ...

  • Industries : Biological Therapy
U.S. Stem Cell, Inc. (USRM) - Financial and Strategic SWOT Analysis Review

U.S. Stem Cell, Inc. (USRM) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • July 2016
  • by Global Data

U.S. Stem Cell, Inc. (USRM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by ...

  • Industries : Biological Therapy
  • Countries : United States
Antisense Therapeutics Limited (ANP) - Financial and Strategic SWOT Analysis Review

Antisense Therapeutics Limited (ANP) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • June 2016
  • by Global Data

Antisense Therapeutics Limited (ANP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : Therapy, Biological Therapy
Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review

Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2016
  • by Global Data

Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled ...

  • Industries : General Medicine and Specialty Medicine
Northwest Biotherapeutics, Inc. (NWBO) - Financial and Strategic SWOT Analysis Review

Northwest Biotherapeutics, Inc. (NWBO) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • May 2016
  • by Global Data

Northwest Biotherapeutics, Inc. (NWBO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been ...

  • Industries : Cancer, Pathology, Biological Therapy
Japan Tissue Engineering Company Limited

Japan Tissue Engineering Company Limited

  • $ 99
  • Company report
  • July 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Japan Tissue Engineering Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, ...

  • Industries : Biological Therapy
  • Countries : Japan
US Stem Cell Inc

US Stem Cell Inc

  • $ 99
  • Company report
  • July 2016
  • by Wright Investors' Service

A textual analysis of the financial results for US Stem Cell Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Biological Therapy
  • Countries : United States
Antisense Therapeutics Limited

Antisense Therapeutics Limited

  • $ 99
  • Company report
  • July 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Antisense Therapeutics Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biological Therapy
  • Countries : United States, World
Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc.

  • $ 99
  • Company report
  • June 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Northwest Biotherapeutics, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biological Therapy
  • Countries : United States
Eleven Biotherapeutics Inc

Eleven Biotherapeutics Inc

  • $ 99
  • Company report
  • June 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Eleven Biotherapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

  • Industries : Biological Therapy
  • Countries : United States
Asterias Biotherapeutics Inc

Asterias Biotherapeutics Inc

  • $ 99
  • Company report
  • June 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Asterias Biotherapeutics Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

  • Industries : Biological Therapy, Biotechnology
  • Countries : United States, World
GEH/FedDev/CCRM – Toronto Centre for Advanced Therapeutic Cell Technologies – Ontario - Construction Project Profile

GEH/FedDev/CCRM – Toronto Centre for Advanced Therapeutic Cell Technologies – Ontario - Construction Project Profile

  • $ 75
  • Industry report
  • June 2016
  • by Timetric

Synopsis "GEH/FedDev/CCRM – Toronto Centre for Advanced Therapeutic Cell Technologies – Ontario - Construction Project Profile" contains information on the scope of the project including project overview ...

  • Industries : Biological Therapy, Construction
  • Countries : Canada
Global Hematological Cancers Market to 2022 - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market

Global Hematological Cancers Market to 2022 - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market

  • $ 4 995
  • Industry report
  • April 2016
  • by GBI Research

Global Hematological Cancers Market to 2022 - Commercially Successful Targeted Therapies and Large, Innovative Pipeline to Drive Market Summary Hematological malignancies are a class of cancer that affect ...

  • Industries : Cancer, Pathology
  • Countries : World
Kidney Transplantation - Pipeline Review, H1 2016

Kidney Transplantation - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • April 2016
  • by Global Markets Direct

Kidney Transplantation - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Kidney Transplantation - Pipeline Review, H1 2016’, provides an overview of the Kidney Transplantation pipeline ...

  • Industries : Medical Device, Healthcare, Pathology, Therapy
  • Countries : United States
Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2016

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • April 2016
  • by Global Markets Direct

Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2016’, provides an overview ...

  • Industries : Pathology, Mental Health, Therapy
  • Countries : United States
CureVac GmbH - Product Pipeline Review - 2016

CureVac GmbH - Product Pipeline Review - 2016

  • $ 1 500
  • Company report
  • April 2016
  • by Global Markets Direct

CureVac GmbH - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘CureVac GmbH - Product Pipeline Review - 2016’, provides an overview of the CureVac GmbH’s pharmaceutical research ...

  • Industries : Biopharmaceutical, Biotechnology, Research and Development, Therapy, Biological Therapy
  • Countries : United States
Leber Congenital Amaurosis (LCA) - Pipeline Review, H1 2016

Leber Congenital Amaurosis (LCA) - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • April 2016
  • by Global Markets Direct

Leber Congenital Amaurosis (LCA) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Leber Congenital Amaurosis (LCA) - Pipeline Review, H1 2016’, provides an overview of the Leber Congenital ...

  • Industries : Therapy, Pharmaceutical
  • Countries : United States
Hepatitis C - Pipeline Review, H1 2016

Hepatitis C - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • April 2016
  • by Global Markets Direct

Hepatitis C - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H1 2016’, provides an overview of the Hepatitis C pipeline landscape. The report provides comprehensive ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Hemophilia B - Pipeline Review, H1 2016

Hemophilia B - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • April 2016
  • by Global Markets Direct

Hemophilia B - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hemophilia B - Pipeline Review, H1 2016’, provides an overview of the Hemophilia B pipeline landscape. The report provides ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2016

Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2016

  • $ 2 500
  • Company report
  • April 2016
  • by Global Data

Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Cytomegalovirus (HHV-5) Infections Global Clinical Trials Review, H1, 2016" provides ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Global Tissue Engineering and Regeneration Industry 2016 Market Research Report

Global Tissue Engineering and Regeneration Industry 2016 Market Research Report

  • $ 2 800
  • Industry report
  • April 2016
  • by QY Research Group

The Global Tissue Engineering and Regeneration Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Tissue Engineering and Regeneration industry. Firstly, ...

  • Industries : Biological Therapy, Genomics, Biotechnology
  • Countries : World
Global Stem Cell Therapy Industry 2016 Market Research Report

Global Stem Cell Therapy Industry 2016 Market Research Report

  • $ 2 850
  • Industry report
  • April 2016
  • by 9Dimen Research

2016 Global Stem Cell Therapy Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Stem Cell Therapy industry, focusing on the main regions ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Asia, North America
Global Immunotherapy Drugs Industry 2016 Market Research Report

Global Immunotherapy Drugs Industry 2016 Market Research Report

  • $ 2 850
  • Industry report
  • April 2016
  • by 9Dimen Research

2016 Global Immunotherapy Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Immunotherapy Drugs industry, focusing on the main ...

  • Industries : Biological Therapy
  • Countries : World, Europe, Asia, North America
Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review

Tissue Therapies Limited (TIS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2016
  • by Global Data

Summary Tissue Therapies Limited (TTL) is a heath biotechnology company that develops, manufactures and markets synthetic proteins. The company develops treatments for acute and chronic wound healing applications ...

  • Industries : Biological Therapy
International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

International Stem Cell Corporation (ISCO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2016
  • by Global Data

Summary International Stem Cell Corporation (ISCC) is a biotechnology company that develops technology solutions. The company develops parthenogenesis, a stem cell technology that improves the field of ...

  • Industries : Biological Therapy
Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2016
  • by Global Data

Summary Pathfinder Cell Therapy, Inc. (Pathfinder) is a regenerative medicine company that develops novel based therapies. The company has discovered a new mammalian cell type which is able to stimulate ...

  • Industries : Biological Therapy
Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic SWOT Analysis Review

Protalix BioTherapeutics, Inc. (PLX) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • April 2016
  • by Global Data

Summary Protalix BioTherapeutics, Inc. (Protalix) is a biopharmaceutical company that develops and commercializes recombinant therapeutic proteins through its procellex plant cell-based protein expression ...

  • Industries : Biological Therapy

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.